Efficacy and safety of switching to ixekizumab in secukinumab nonresponder psoriatic patients: results from a multicenter experience
Conti, A., Peccerillo, F., Amerio, P., Balato, A., Bardazzi, F., Bianchi, L., Burlando, M., Cannavò, S.P., Chiricozzi, A., Dapavo, P., De Simone, C., Fargnoli, M.C., Gambardella, A., Gisondi, P., MalaLanguage:
english
Journal:
British Journal of Dermatology
DOI:
10.1111/bjd.17580
Date:
December, 2018
File:
PDF, 172 KB
english, 2018